Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7251–7300 of 75468
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Sandy Spring’s directors and executive officers ceased serving as directors and executive officers of Sandy Spring.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Sandy Spring’s directors and executive officers ceased serving as directors and executive officers of Sandy Spring.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Sandy Spring’s directors and executive officers ceased serving as directors and executive officers of Sandy Spring.
Thomas M. O’Brien stepped down as Chairman, President and Chief Executive Officer
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Christine Meredith stepped down as Chief Operating Officer
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Elizabeth M. Keogh stepped down as Chief Legal Officer and Corporate Secretary
Steven E. Gallotta has been appointed Chairman of the Board
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Karen Knott stepped down as Executive Vice President
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Eleni Willis stepped down as Chief Risk Officer
The three directors of Sandy Spring mutually agreed by the Company and Sandy Spring, each of whom previously served as a member of the board of directors of Sandy Spring immediately prior to the Merger and was appointed by the Board to fill the vacancies resulting from the increase in the size of the Board referred to above, in each case effective as of the Effective Time, are as follows: Daniel J. Schrider, Mona Abutaleb Stephenson and Mark C. Micklem (collectively, the “New Directors”).
The three directors of Sandy Spring mutually agreed by the Company and Sandy Spring, each of whom previously served as a member of the board of directors of Sandy Spring immediately prior to the Merger and was appointed by the Board to fill the vacancies resulting from the increase in the size of the Board referred to above, in each case effective as of the Effective Time, are as follows: Daniel J. Schrider, Mona Abutaleb Stephenson and Mark C. Micklem (collectively, the “New Directors”).
The three directors of Sandy Spring mutually agreed by the Company and Sandy Spring, each of whom previously served as a member of the board of directors of Sandy Spring immediately prior to the Merger and was appointed by the Board to fill the vacancies resulting from the increase in the size of the Board referred to above, in each case effective as of the Effective Time, are as follows: Daniel J. Schrider, Mona Abutaleb Stephenson and Mark C. Micklem (collectively, the “New Directors”).
On March 27, 2025, W. Thorpe McKenzie informed the Board of Directors (the “Board”) of XBiotech Inc. (the “Company”) via letter of his decision to retire from the Board, effective immediately.
On April 1, 2025, Mr. Moller was appointed Principal Accounting Officer
and Todd W. Garner, Executive Vice President of Finance and Chief Financial Officer, ceased serving in the role of Principal Accounting Officer.
Kimberly A. Lockwood, who was acting as Interim Corporate Controller, has been promoted to Senior Director of Financial Reporting.
Simon Tate notified Climb Bio, Inc. (the “Company”) of his decision to resign as a member of the Company’s board of directors
Mr. Cumbo was elected to serve with a term expiring at the Company’s 2026 annual meeting of stockholders and thereafter until his successor has been duly appointed and qualified or until his earlier death, resignation or removal.
Ms. Drapkin was elected to serve with a term expiring at the Company’s 2027 annual meeting of stockholders and thereafter until her successor has been duly appointed and qualified or until her earlier death, resignation or removal.
Adam Rosenberg notified the Company that he does not intend to seek re-election as a member of the Board when his current term ends at the Company’s 2025 annual meeting of stockholders.
Terrie Curran who resigned as President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”) for personal reasons, effective March 31, 2025.
Steven Basta was appointed as the Chief Executive Officer, President and as a Class I director of Phathom Pharmaceuticals, Inc. (the “Company”), replacing Terrie Curran who resigned as President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”) for personal reasons, effective March 31, 2025.
On March 31, 2025, Todd M. Ricketts notified the Board of Directors (the “Board”) of The Charles Schwab Corporation of his intention to retire from the Board effective October 7, 2025.
On April 1, 2025, Kohl’s Corporation (the “Company”) announced that Siobhán Mc Feeney, the Company’s Chief Technology and Digital Officer, will be departing the Company effective April 2, 2025.
On March 27, 2025, Matthew Lang, J.D. notified the Company of his resignation as Chief Business Officer and from all other offices of the Company, effective April 13, 2025.
On March 28, 2025, Ng Ah Lek resigned from his positions as an Independent Director of Graphjet Technology (the “Company”) and as a member of the Company’s Audit Committee, Renumeration Committee, and Nominating and Corporate Governance Committee.
Effective April 1, 2025, following ten years of board membership, Israel Niv retired as a member of the board of directors (the “Board”) of Actelis Networks, Inc. (the “Company”), and as member of the committees of the Board.
On March 26, 2025, Abhishek Bawa notified the board of directors (the "Board") of ClimateRock (the "Company") of his resignation as Chief Financial Officer of the Company, effective on March 26, 2025.
On April 1, 2025, iHeartMedia, Inc. (the “Company”) announced that it intends to nominate Robert Millard as a director of the Company at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
On March 26, 2025, Brad Gerstner informed the Company of his intention not to stand for re-election to the Board at the Company’s 2025 Annual Meeting to focus on other commitments and accordingly, his term will end on the date of the 2025 Annual Meeting.
First Northwest Bancorp ("First Northwest") and its wholly owned subsidiary First Fed Bank ("First Fed" and, together with First Northwest, the "Company") has announced that on March 27, 2025, Phyllis Nomura was appointed Executive Vice President and Chief Financial Officer / Treasurer of the Company, effective immediately.
On March 27, 2025, BJ North, Plumas Bank’s Executive Vice President and Chief Banking Officer, notified the bank that she intends to retire effective on July 15, 2025.
On March 26, 2025, the board of directors of the Company (the “Board”) appointed Greg Lipschitz as the Chief Executive Officer of the Company.
On April 1, 2025 (the “ Effective Date ”), Universal Biosensors, Inc. (the “ Company ”) announced that John Sharman resigned from his position as Chief Executive Officer and Managing Director on the Board of Directors (the “ Board ”) of the Company, effective on the Effective Date.
On the Effective Date, the Company announced that the Board appointed Peter Mullin as Chief Executive Officer and Managing Director of the Board, effective as of the Effective Date.
The Company has appointed Rajal Mehta as Interim Chief Financial Officer effective upon Mr. Edwards’ departure.
On March 27, 2025, Thomas J. Edwards, Jr., Executive Vice President, Chief Financial Officer and Chief Operating Officer of Capri Holdings Limited (the “ Company ”) notified the Company of his decision to resign from his position, effective June 20, 2025, to pursue another opportunity.
Frank E. Jenkins, Jr., a former director of Village, was appointed to the board of directors of TowneBank effective as of the effective time of the Transaction.
James E. Hendricks, Jr., former President and Chief Executive Officer of Village, became a Senior Executive Vice President of TowneBank at the effective time of the Transaction.
agreed that Dr. Jansen would step down as Chief Medical Officer effective March 31, 2025
On March 31, 2025, the Board appointed Lawrence S. Massaro to serve as a member of the board of directors (the “ Board ”) of TXO Partners GP, LLC (the “ General Partner ”), the general partner of TXO Partners, L.P. (the “ Partnership ”), effective April 1, 2025.
Effective as of April 1, 2025, Salvatore Mulia, a member of the NewtekOne, Inc. Board of Directors (the “Board”) since 2004, retired as a member of the Board.
Coincident to Ms. Lachance's appointment, Scott Shuda was appointed Executive Chairman of the Company's Board.
The Board has appointed Carrie Lachance as the new CEO, effective as of the Separation Date.
Mr. DiIorio will step down as the Company's Chief Executive Officer ("CEO"), effective May 19, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.